| |
|
Georgia Cusack, MS, RN, AOCNS®, Honored as 2013 AOCNS® of the Year
Awards Granted;
05/03/2013
The Oncology Nursing Certification Corporation (ONCC) has selected Georgia “Georgie” Cusack, MS, RN, AOCNS®, as the 2013 Advanced Oncology Certified Nurse of the Year. Cusack was selected for the award based on her contributions to oncology nursing and oncology nursing service, and for supporting and promoting certification in oncology nursing.
|
|
Marsha Richardson, RN, MSN, OCN®, CBCN®, Named 2013 Certified Breast Care Nurse of the Year
Awards Granted;
05/03/2013
The Oncology Nursing Certification Corporation (ONCC) has selected Marsha Richardson, RN, MSN, OCN®, CBCN® as the 2013 Certified Breast Care Nurse of the Year. Richardson was selected for the award for her contributions to breast care nursing and nursing service; and for supporting and promoting certification in breast care/oncology nursing. She is the oncology program coordinator/breast cancer navigator at Parrish Medical Center in Titusville, FL.
|
|
ONCC Honors Saint Peter’s University Hospital with 2013 Employer Recognition Award
Awards Granted;
05/03/2013
The Oncology Nursing Certification Corporation (ONCC) has named Saint Peter’s University Hospital in New Brunswick, NJ, as the recipient of its 2013 Employer Recognition Award. Each year, this award recognizes one institution that employs 25 or more registered nurses for providing sustained support of oncology nursing certification.
|
|
ONCC Names Janine Kokal, MS, RN, OCN®, 2013 Oncology Certified Nurse of the Year
Awards Granted;
05/03/2013
The Oncology Nursing Certification Corporation (ONCC) has selected Janine Kokal, MS, RN, OCN®, as the 2013 Oncology Certified Nurse of the Year. Kokal was selected for the award for her contributions to oncology nursing and oncology nursing service and for supporting and promoting certification in oncology nursing. She is an educator with the Mayo Clinic Cancer Education Program in Rochester, MN.
|
|
ONS Announces 2013-2014 Board of Directors
ONS News;
04/27/2013
The Oncology Nursing Society (ONS) announced its 2013–2014 Board of Directors at its 38th Annual Congress in Washington, DC.
|
|
ONS Announces 2013 Distinguished Award Winners
ONS News;
04/25/2013
The Oncology Nursing Society (ONS) honored the following award recipients during the opening ceremony of the ONS 38th Annual Congress in Washington, DC.
|
|
Expanded Preview Provides Look at New Areas of the ONS Website Redesign
ONS News;
04/08/2013
Several exciting new features are now available on the expanded preview of ONS's redesigned website. You asked, and we listened. In response to your feedback, ONS has been in the process of redesigning our website from the ground up. Because we care about the best interests of oncology nurses, we've looked at your questions, comments, and usage data to design a site entirely focused on helping you get to the information you need as quickly and easily as possible. Check out the expanded preview site on any device.
|
|
ONS Website Redesign Reaches Two New Milestones
ONS News;
03/19/2013
In response to member feedback, ONS is in the process of redesigning our website from the ground up to offer a site entirely focused on helping oncology nurses get to the information they need as quickly and easily as possible.
The launch of two exciting developments in this process is right around the corner: a brand-new ONS profile site, as well as an expanded beta preview of our new website. More details will be available in April when each of these launches.
|
|
ONS Wins 2012 AJN Book of the Year Honor
ONS News;
01/25/2013
The Oncology Nursing Society (ONS) is pleased to announce that Self-Healing Through Reflection, A Workbook for Nurses published by Hygeia Media, an imprint of ONS, won second place in the prestigious 2012 American Journal of Nursing (AJN) Book of the Year Award in the professional development and issues category.
|
|
ONS Receives Grant From AHRQ to Test New Strategies to Improve the Quality of Cancer Care
ONS News;
01/15/2013
As cancer care is delivered more often in ambulatory settings or during very short hospital stays, the role of family members and other caregivers is becoming increasingly important in the care of patients with cancer. The Oncology Nursing Society (ONS) has received a three-year grant from the Agency for Healthcare Research and Quality (AHRQ) to develop and examine innovative electronic communication methods to disseminate ONS’s research-based resources to healthcare providers to help improve the quality of patient care.
|
|
ONS Releases Position on Cancer Genetics and Genomics
ONS News;
01/10/2013
Oncology nurses’ understanding and application of cancer genetics and genomics can change and improve the practice of general oncology nurses and advanced practice nurses in the course of patient risk assessment, prevention, screening, and treatment of cancer. A new position released by the Oncology Nursing Society (ONS) encourages the integration of new evidence-based genetic and genomic information into oncology nursing practice and the education of patients and the public about the potential benefits and limitations of genetic and genomic testing.
|
|
ONS Selects Schoology to Enhance the Continuing Education of Members
ONS News;
12/20/2012
The Oncology Nursing Society (ONS) is pleased to announce that it has selected the Schoology platform as its preferred learning management system. ONS will use Schoology to connect members to its latest research, training, and continuing education resources.
|
|
FDA Grants Accelerated Approval to Ponatinib
FDA Updates;
12/14/2012
The U.S. Food and Drug Administration granted accelerated approval to ponatinib (Iclusig™ tablets, ARIAD Pharmaceuticals, Inc.) for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.
|
|
FDA Approves Expanded Indication for Abiraterone Acetate
FDA Updates;
12/10/2012
The U.S. Food and Drug Administration approved an expanded indication for abiraterone acetate (Zytiga® Tablets, Janssen Biotech, Inc.) in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.
|
|
FDA Approves Cabozantinib
FDA Updates;
11/29/2012
The U.S. Food and Drug Administration approved cabozantinib (COMETRIQ™ capsules, Exelixis, Inc), for the treatment of patients with progressive metastatic medullary thyroid cancer (MTC).
|
|
Critical Nursing Leadership Skills Identified in ONS Leadership Competencies
ONS News;
11/14/2012
Nurses are the largest profession of healthcare workers in the United States and are at the forefront of patient care. In today’s complex healthcare delivery environment, nurses must be leaders at all levels of the profession. The Oncology Nursing Society (ONS) is pleased to announce the release of the ONS Leadership Competencies which are designed to reflect the specific needs of oncology nurses, but can transcend practice settings and be used universally across nursing specialties to increase and measure leadership competency in any environment.
|
|
ONS Journals Unveil Advanced Print Exclusive Articles
ONS News;
11/08/2012
Starting in November 2012, advanced print exclusive articles for CJON will be available on MetaPress under the advanced print exclusive tab. These articles will be open access, meaning they are available to members and non-members alike, until they appear in print at a later date. At that time, the content will become password-protected like all of the other articles that appear in print as online exclusives in the journals.
|
|
FDA Grants Approval to Omacetaxine Mepesuccinate
FDA Updates;
10/26/2012
The U.S. Food and Drug Administration (FDA) granted accelerated approval to omacetaxine mepesuccinate, (SYNRIBO® for Injection, for subcutaneous use, Teva Pharmaceutical Industries Ltd.), for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKIs).
|
|
FDA Approves Infusion for Rituximab
FDA Updates;
10/19/2012
The U.S. Food and Drug Administration approved a 90-minute infusion for rituximab (Rituxan® Injection, Genentech, Inc.) starting at Cycle 2 for patients with non-Hodgkin’s lymphoma (NHL) who did not experience a grade 3 or 4 infusion-related adverse reaction during Cycle 1.
|
|
FDA Expands Labeling of Pemetrexed
FDA Updates;
10/17/2012
The U.S. Food and Drug Administration expanded labeling to include the results of an additional trial evaluating the safety and efficacy of pemetrexed (ALIMTA®, Eli Lilly and Company) for the initial treatment of patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer followed by pemetrexed maintenance in patients whose disease has not progressed after four cycles of platinum and pemetrexed as first-line chemotherapy.
|
|
FDA Approves Abraxane® Protein-Bound Particles for Injectable Suspension
FDA Updates;
10/11/2012
The US Food and Drug Administration approved paclitaxel protein-bound particles for injectable suspension, albumin-bound (ABRAXANE® for Injectable Suspension; Abraxis Bioscience a wholly owned subsidiary of Celgene Corporation) for use in combination with carboplatin for the initial treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are not candidates for curative surgery or radiation therapy.
|
|
ONS Foundation Awards Grant for Pilot Research on Lung Cancer Symptom Management
ONS News;
10/10/2012
The ONS Foundation has awarded Marie Flannery, PhD, RN, AOCN®, a $10,000 Trish Greene Pain Assessment and Management Research Grant, sponsored by Purdue Pharma L.P.
|
|
Advanced Print Exclusives Give ONS Journal Readers Early Access to Articles
ONS News;
10/09/2012
The Oncology Nursing Society (ONS) is pleased to announce that the journals Oncology Nursing Forum (ONF) and Clinical Journal of Oncology Nursing (CJON) are unveiling advanced print exclusive articles to give readers access to important, cutting-edge content ahead of print.
|
|
FDA Approves Regorafenib
FDA Updates;
09/27/2012
The U.S. Food and Drug Administration approved regorafenib (Stivarga® tablets, Bayer HealthCare Pharmaceuticals, Inc.), for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy.
|
|
ONS Celebrates National Health IT Week
ONS News;
09/11/2012
Health information technology (HIT) improves the quality of healthcare delivery, increases patient safety, decreases medical errors, and strengthens the interaction between patients and healthcare providers.
|
|
ONS Launches Seal of Approval Program
ONS News;
09/07/2012
The Oncology Nursing Society’s (ONS) Seal of Approval program is designed to assist healthcare professionals and consumers in selecting quality educational materials related to cancer care.
|
|
ONS Welcomes New Sponsor of Recognition Program Honoring Oncology Nurses
ONS News;
09/07/2012
The Oncology Nursing Society (ONS) welcomes Millennium: The Takeda Oncology Company as a co-sponsor of the ONS Honor Someone Special recognition program.
|
|
FDA Approves Bosutinib Tablets for Adult Patients with CML
FDA Updates;
09/04/2012
The U.S. Food and Drug Administration (FDA) approved bosutinib tablets (Bosulif®, Pfizer, Inc.) for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) in adult patients with resistance or intolerance to prior therapy.
|
|
FDA Approved Enzalutamide (XTANDI® Capsules)
FDA Updates;
08/31/2012
The U.S. Food and Drug Administration (FDA) approved enzalutamide (XTANDI® Capsules, Medivation, Inc. and Astellas Pharma US, Inc.), for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.
|
|
FDA Grants Accelerated Approval to Afinitor Disperz®
FDA Updates;
08/29/2012
The U.S. Food and Drug Administration granted accelerated approval for everolimus tablets for oral suspension (Afinitor Disperz®, Novartis Pharmaceuticals Corp.) for the treatment of pediatric and adult patients with tuberous sclerosis complex (TSC) who have subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be curatively resected.
|
|
ONCC Launches New Certification for Blood and Marrow Transplant Nurses
ONS News;
08/24/2012
The Oncology Nursing Certification Corporation (ONCC) announces it will offer a new certification program in blood and marrow transplantation (BMT) nursing. The first Blood and Marrow Transplantation Certified Nurse Examination will be offered in February 2014. Nurses who pass the test will earn the credential “BMTCN.”
|
|
ONS Receives Publishing Award
ONS News;
08/20/2012
The American Medical Writers Association (AMWA) has recognized the Oncology Nursing Society (ONS) with an Honorable Mention award for the book Nursing Management: Principles and Practice, 2nd ed. in the Non-Physician Category.
|
|
FDA Grants Accelerated Approval for Vincristine Sulfate Liposome Injection
FDA Updates;
08/09/2012
The U.S. Food and Drug Administration (FDA) granted accelerated approval for vinCRIStine sulfate LIPOSOME injection (Marqibo®, Talon Therapeutics, Inc.) for the treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies.
|
|
ONS to Host Radiation eConference
ONS News;
08/09/2012
Nurses want—and need—quality radiation education without the high costs of travel. That’s exactly what the Oncology Nursing Society (ONS) Radiation eConference delivers.
|
|
FDA Approves Ziv-Aflibercept Injection (ZALTRAP®)
FDA Updates;
08/03/2012
The U.S. Food and Drug Administration approved ziv-aflibercept injection (ZALTRAP®, Sanofi U.S., Inc.) for use in combination with 5-fluorouracil, leucovorin, irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin containing regimen.
|
|
FDA Approves Everolimus Tablets
FDA Updates;
07/20/2012
The U.S. Food and Drug Administration (FDA) approved everolimus tablets (Afinitor®, Novartis Pharmaceuticals Corporation) for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane, after failure of treatment with letrozole or anastrozole.
|
|
FDA Grants Accelerated Approval to Carfilzomib Injection
FDA Updates;
07/20/2012
The U.S. Food and Drug Administration (FDA) granted accelerated approval to carfilzomib injection (Kyprolis™, Onyx Pharmaceuticals), for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of the completion of the last therapy.
|
|
ONS Joins Forces to Support U.S. Service Members and Their Families
Press Releases;
07/12/2012
ONS has joined forces with the American Nurses Association (ANA) and other nursing groups to support Joining Forces, a nonpartisan national initiative led by the White House and First Lady Michelle Obama to mobilize all sectors of the community to support service members and their families.
|
|
ONS Welcomed Into the Alliance for Nursing Informatics
ONS News;
07/12/2012
The Oncology Nursing Society (ONS) is pleased to announce that it has been granted full membership into the Alliance for Nursing Informatics (ANI). ANI is a collaboration of organizations that represents more than 5,000 nurse informaticists and brings together 30 distinct nursing informatics groups globally.
|
|
ONS Releases Position on Access to Quality Cancer Care
ONS News;
07/10/2012
Access to quality cancer care is the right of all people. A new position released by the Oncology Nursing Society (ONS) affirms that affordable and accessible comprehensive healthcare coverage with respect to cancer prevention, early detection, risk assessment, and other factors should be available to everyone regardless of personal or family history or preexisting conditions.
|
|
FDA Approves Cetuximab For Use in Combination With FOLFIRI
FDA Updates;
07/06/2012
The U.S. Food and Drug Administration granted approval to cetuximab (Erbitux®, ImClone LLC, a wholly owned subsidiary of Eli Lilly and Co) for use in combination with FOLFIRI (irinotecan, 5-fluorouracil, leucovorin) for first-line treatment of patients with K-ras mutation-negative (wild-type), EGFR-expressing metastatic colorectal cancer (mCRC) as determined by FDA-approved tests for this use.
FDA also approved the Therascreen® KRAS RGQ PCR Kit (QIAGEN Manchester, Ltd) concurrent with this cetuximab approval.
|
|
ONS Journal Oncology Nursing Forum Achieves Top Impact Factor
ONS News;
07/05/2012
The Oncology Nursing Society (ONS) is pleased to announce that the Oncology Nursing Forum (ONF) is ranked first for impact factor among 97 journals in the nursing category from 2011 Journal Citation Reports® (Thomson Reuters, 2011). The impact factor measures the number of times that articles within a particular journal are cited, thereby measuring the impact that they have on the literature.
|
|
Beth Faiman, MSN, APRN-BC, AOCN®, Receives 2012 ONS Excellence in Medical Oncology Award
Awards Granted;
07/03/2012
Beth Faiman, MSN, APRN-BC, AOCN®, is the recipient of the 2012 Oncology Nursing Society (ONS) Excellence in Medical Oncology Award. Faiman is a nurse practitioner at Cleveland Clinic and a PhD candidate at the Frances Payne Bolton School of Nursing at Case Western Reserve University in Cleveland, OH.
|
|
Wendy Vogel, MSN, FNP, AOCNP®, Receives 2012 Oncology Nursing Society Mary Nowotny Excellence in Cancer Nursing Education Award
Awards Granted;
07/03/2012
Wendy Vogel, MSN, FNP, AOCNP® is the recipient of the Oncology Nursing Society (ONS) Mary Nowotny Excellence in Cancer Nursing Education Award for 2012. Vogel is an oncology nurse practitioner at Kingsport Hematology Oncology Associates in Kingsport, TN.
|
|
ONS Receives Awards for Publishing Excellence
ONS News;
06/15/2012
The Oncology Nursing Society (ONS) was honored for its publishing excellence by Association Media & Publishing (AMP) at AMP’s annual Awards Gala.
|
|
Elizabeth Lee Krayk, RN, BSN, OCN®, Receives 2012 ONS Pearl Moore "Making a Difference" Frontline Care Award
Awards Granted;
06/13/2012
– Elizabeth Lee Krayk, RN, BSN, OCN®, is the recipient of the 2012 Oncology Nursing Society (ONS) Pearl Moore “Making a Difference” Frontline Care Award. She is an RN, clinical nurse III at Renown Regional Medical Center in Reno, NV. This award recognizes her as a frontline oncology nurse who demonstrates exceptional patient care through the use of evidence-based practice.
|
|
FDA Approves Pertuzumab Injection
FDA Updates;
06/08/2012
The U.S. Food and Drug Administration approved pertuzumab injection (PERJETA™, Genentech, Inc.) for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease. Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of HER2, and thereby blocks ligand-dependent heterodimerization of HER2 with other HER family members, including EGFR, HER3 and HER4.
|
|
Michelle Wallace, RN, BSN, OCN®, Receives 2012 ONS Excellence in Radiation Therapy Nursing Award
Awards Granted;
06/07/2012
Michelle Wallace, RN, BSN, OCN®, is the recipient of the 2012 Oncology Nursing Society (ONS) Excellence in Radiation Therapy Nursing Award. Wallace is a nurse clinician in radiation oncology at Beaumont Health System in Royal Oak, MI. This award recognizes her as an expert oncology nurse in the field of radiation oncology who made significant contributions to the field through outstanding patient care.
|
|
Jill Reese, RN, BSN, OCN® Receives 2012 ONS Excellence in Patient/Public Education Award
Awards Granted;
06/06/2012
Jill M. Reese, RN, BSN, OCN®, is the recipient of the 2012 Oncology Nursing Society (ONS) Excellence in Patient/Public Education Award. Reese is a clinical educator at Dayton Physicians, LLC, in Dayton, OH. This award recognizes her as an oncology nurse involved in offering creative and innovative educational programming for her patients, their families, and her community.
|
|
ONS Columbus Chapter Receives 2012 Pearl Moore “Making a Difference” Team Achievement Award
Awards Granted;
05/31/2012
The Community Outreach Committee of the Columbus Chapter of the Oncology Nursing Society (CCONS) is the 2012 recipient of the Pearl Moore “Making a Difference” Team Achievement Award. This award recognizes outstanding contributions within the workplace in improving patient care or making a difference in the community.
|
|
Ayda Nambayan, DSN, RN, Receives 2012 ONS International Award for Contributions to Cancer Care
Awards Granted;
05/29/2012
Ayda G. Nambayan, DSN, RN, is the 2012 recipient of the Oncology Nursing Society (ONS) Pearl Moore International Award for Contributions to Cancer Care. Nambayan is Consultant for Advanced Education and Professional Training and Director of Nursing Education and Research at The Cancer Center, Makati Medical Center, in Manila, Philippines.
|
|
Susan Beck, PhD, APRN, AOCN, FAAN, Receives 2012 ONS Distinguished Researcher Award
Awards Granted;
05/29/2012
Susan Larsen Beck, PhD, APRN, AOCN®, FAAN, has been named the Oncology Nursing Society’s (ONS) 2012 Distinguished Researcher. Beck is Professor and Robert S. and Beth M. Carter Endowed Chair in Nursing at the University of Utah College of Nursing in Salt Lake City. The honor recognizes her outstanding research contributions that have enhanced the science and practice of oncology nursing.
|
|
Patricia Frank, RN, BSN, Receives 2012 ONS Emerging Leader Award
Awards Granted;
05/18/2012
Patricia Frank, RN, BSN, is the recipient of the 2012 Oncology Nursing Society (ONS) Pearl Moore “Making a Difference” Emerging Leader Award. This award recognizes her as an emerging oncology nurse leader who has made a difference in the oncology nursing profession at the local or regional level.
|
|
Anna Schwartz, PhD, FNP, FAAN, Receives 2012 ONS Distinguished Contribution to Nursing Literature Award
Awards Granted;
05/16/2012
Anna Schwartz, PhD, FNP, FAAN, of Wilson, WY, associate professor at Idaho State University in Pocatello and affiliate professor at the University of Washington in Seattle, is the recipient of the Oncology Nursing Society (ONS) 2012 Rose Mary Carroll-Johnson Distinguished Award for Consistent Contribution to the Nursing Literature.
|
|
Laura Wood, RN, MSN, OCN®, Presents 2012 ONS Clinical Lecture
Awards Granted;
05/16/2012
Laura Wood, RN, MSN, OCN®, presented the 2012 Oncology Nursing Society (ONS) Clinical Lecture at the ONS 37th Annual Congress which was held May 3-6 in New Orleans, LA.
|
|
Kelly Smith, MSN, RN, NP, AOCN, Named 2012 Advanced Oncology Certified Nurse of the Year
Awards Granted;
05/11/2012
The Oncology Nursing Certification Corporation (ONCC) has selected Kelly Smith, MSN, RN, NP, AOCN® as the 2012 Advanced Oncology Certified Nurse of the Year. Smith was selected for the award for her contributions to oncology nursing and oncology nursing service; and for supporting and promoting certification in oncology nursing.
|
|
ONCC Honors Froedtert Hospital
Awards Granted;
05/11/2012
The Oncology Nursing Certification Corporation (ONCC) has named Froedtert Hospital in Milwaukee, WI, as a recipient of its 2012 Employer Recognition Award. Each year, this award recognizes one institution that employs 25 or more registered nurses for providing sustained support of oncology nursing certification.
|
|
ONCC Honors Moncrief Cancer Institute
Awards Granted;
05/11/2012
The Oncology Nursing Certification Corporation (ONCC) has selected Moncrief Cancer Institute in Fort Worth, TX, as a recipient of its 2012 Employer Recognition Award. Each year, this award recognizes one organization that employs less than 25 registered nurses for providing sustained support of certification in oncology nursing.
|
|
Sylvia Danko, RN, BSN, OCN, CBCN, Named 2012 Oncology Certified Nurse of the Year
Awards Granted;
05/11/2012
The Oncology Nursing Certification Corporation (ONCC) has selected Sylvia Danko, RN, BSN, OCN®, CBCN® as the 2012 Oncology Certified Nurse of the Year. Danko was selected for the award for her contributions to oncology nursing and oncology nursing service, and for supporting and promoting certification in oncology nursing.
|
|
ONS Announces 2012-2013 Board of Directors
ONS News;
05/05/2012
The Oncology Nursing Society (ONS) announced its 2012–2013 Board of Directors at its 37th Annual Congress in New Orleans, LA.
|
|
FDA Approves Pazopanib Tablets
FDA Updates;
04/26/2012
The U.S. Food and Drug Administration approved pazopanib tablets (VOTRIENT®, a registered Trademark of GlaxoSmithKline) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy.
|
|
FDA Grants Approval to Everolimus
FDA Updates;
04/26/2012
The U.S. Food and Drug Administration granted accelerated approval to everolimus (Afinitor tablets, Novartis) for the treatment of adults with renal angiomyolipoma, associated with tuberous sclerosis complex (TSC), who do not require immediate surgery.
|
|
The Regional Cancer Center Receives ONS Employer Recognition Award
Awards Granted;
04/18/2012
The Oncology Nursing Society (ONS) has selected The Regional Cancer Center (RCC) in Erie, PA, as the recipient of its 2012 Employer Recognition Award for medium-sized employers. This award recognizes employers who show exemplary support of their registered nurses working in oncology. The award will be presented during ONS’s 37th Annual Congress in New Orleans, LA, on May 3–6.
|
|
Report Outlines Innovative Breast Cancer Rehabilitation Model
ONS News;
04/11/2012
The Oncology Nursing Society (ONS) is proud to be part of an international initiative that outlines an innovative model to address a wide range of physical issues faced by women with breast cancer and offers hope for improved function and full participation in life activities for patients through rehabilitation and exercise.
|
|
Carol Reed Ash, EdD, RN, FAAN, Receives 2012 ONS Lifetime Achievement Award
Awards Granted;
04/05/2012
Carol Reed Ash, EdD, RN, FAAN, is the recipient of the 2012 Oncology Nursing Society (ONS) Lifetime Achievement Award. Ash is professor emeritus, Kirbo Endowed Chair, Oncology Nursing at the University of Florida in Gainesville. The award recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large.
|
|
Donna Berry, PhD, RN, AOCN®, FAAN, Receives ONS Foundation Research Grant Award
Awards Granted;
03/22/2012
Donna Berry, PhD, RN, AOCN®, FAAN, is the recipient of an ONS Foundation Endowment Nursing Research Grant for her project entitled, “ESRA-C Spanish: Linguistic Appropriateness and Cultural Sensitivity.”
|
|
Release of USPSTF Final Recommendation on Screening for Cervical Cancer
Legislative Updates;
03/16/2012
Today, the U.S. Preventive Services Task Force posted its final recommendation statement on screening for cervical cancer.
|
|
March is National Colorectal Cancer Awareness Month
Legislative Updates;
03/09/2012
CMS Offers Insight to Colorectal Cancer Awareness Month in March. Of cancers that affect both men and women, colorectal cancer is the second leading cause of cancer-related deaths in the United States and the third most common cancer in men and in women.
|
|
ONS Releases Position on Lifelong Learning
ONS News;
03/09/2012
Cancer care is rapidly changing, and nurses who care for patients with cancer must commit to lifelong learning to have the expert skills and knowledge they need to provide quality cancer care to their patients. The Oncology Nursing Society (ONS) has released a new position statement on this topic.
|
|
FDA’s graphic labeling of tobacco products
Legislative Updates;
03/02/2012
On February 29, DC District Judge Richard Leon overturned a lower Court’s decision allowing the FDA’s graphic labeling of tobacco products.
|
|
ONS Presents Employer Recognition Award to Moffitt Cancer Center
Awards Granted;
03/01/2012
The Oncology Nursing Society (ONS) has selected Moffitt Cancer Center in Tampa, FL, as the recipient of its 2012 Employer Recognition Award for large employers.
|
|
ONCC Receives Accreditation of CPHON® Certification
ONS News;
02/22/2012
The Oncology Nursing Certification Corporation (ONCC) received accreditation of its Certified Pediatric Hematology Oncology Nurse (CPHON®) program from the National Commission for Certifying Agencies (NCCA). The accreditation is valid through April 30, 2015.
|
|
FDA Announces Action to Bolster Supply of Doxil and Methotrexate
FDA Updates;
02/21/2012
The FDA announces major actions taken to bolster the supply of Doxil® (Janssen Research & Development LLC.) and preservative-free formulations of methotrexate.
|
|
ONS Partners With Congressman to Reintroduce Legislation
ONS News;
02/21/2012
The Oncology Nursing Society (ONS) with Representative Steve Israel (D-NY) announced today the unveiling of his legislation, HR 3790, “The Improving Cancer Treatment Education Act of 2012.” The announcement was made at a special event at Huntington Hospital in Long Island, NY.
|
|
ONS Honored with Publishing PROSE Award
ONS News;
02/13/2012
ONS's award-winning publishing division is pleased to announce that it has received an award from the Professional and Scholarly Publishing Division of the Association of American Publishers.
|
|
FDA Grants Regular Approval for Imatinib Mesylate Tablets
FDA Updates;
01/31/2012
The U.S. Food and Drug Administration (FDA) granted regular approval for imatinib mesylate tablets (Gleevec®, Novartis Pharmaceuticals) for the adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive Gastrointestinal Stromal Tumors (GIST).
|
|
The FDA Approves Vismodegib for Metastatic Basal Cell Carcinoma
FDA Updates;
01/30/2012
The U.S. Food and Drug Administration approved vismodegib (ERIVEDGE™ Capsule, Genentech, Inc.) for the treatment of adults with metastatic basal cell carcinoma or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery, and who are not candidates for radiation.
|
|
FDA Approves Axitinib Tablets for Advanced Renal Cell Carcinoma
FDA Updates;
01/27/2012
The U.S. Food and Drug Administration approved axitinib tablets (Inlyta, Pfizer, Inc.) for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.
|
|
ONS Wins 2011 AJN Book of the Year Award
ONS News;
01/26/2012
The American Journal of Nursing (AJN) has awarded the prestigious 2011 AJN Book of the Year Award to the Oncology Nursing Society (ONS) for Advanced Oncology Nursing Certification Review and Resource Manual: Instructor’s Resource, edited by Shirley Triest-Robinson, RN, PhD, AOCNS®, ACNS B, and Wendy H. Vogel, MSN, FNP, AOCNP®, in the Electronic Media category.
|
|
Oncology Nursing Society Announces Anne Katz as Oncology Nursing Forum Editor
ONS News;
01/25/2012
The Oncology Nursing Society (ONS) is pleased to announce Anne Katz, RN, PhD, as the new editor of the Oncology Nursing Forum (ONF), the Society’s flagship journal. Katz will begin her new responsibility on March 1.
|
|
United States Senate Passes a Resolution Recognizing the 40th Anniversary of the National Cancer Act
Legislative Updates;
01/19/2012
A resolution recognizing the 40th anniversary of the National Cancer Act of 1971 and the more than 12,000,000 survivors of cancer alive today because of the commitment of the United States to cancer research and advances in cancer prevention, detection, diagnosis, and treatment.
|
|
FDA Approves Glucarpidase Injection
FDA Updates;
01/17/2012
The US Food and Drug Administration approved glucarpidase injection (Voraxaze®, BTG International Inc.) for the treatment of toxic plasma methotrexate concentrations (> 1 µmol/L) in patients with delayed methotrexate clearance due to impaired renal function.
|
|
FDA Approves Changes to Methotrexate Package Insert
FDA Updates;
12/21/2011
The US Food and Drug Administration has approved changes to the package inserts for methotrexate products for intravenous administration.
|
|
ONS Hosts Health Information Technology Think Tank
ONS News;
12/15/2011
The Oncology Nursing Society (ONS) recently hosted a groundbreaking HIT Think Tank in Pittsburgh, PA, to assess ways to support their members as HIT becomes more a part of everyday life in healthcare organizations.
|
|
ONS Congratulates Lt. General Horoho
Legislative Updates;
12/14/2011
ONS congratulates Lt. General Horoho on her confirmation as the newest Surgeon General of the US Army.
|
|
ONCC Announces Innovative Renewal Method for Certified Nurses
ONS News;
12/09/2011
Nurses who are certified by the Oncology Nursing Certification Corporation (ONCC) will soon have a new method for renewing their certification credentials.
|
|
US Senate Finance Committee Holds Hearing on National Drug Shortage
Legislative Updates;
12/07/2011
The US Senate Finance Committee holds hearing on the national drug shortage.
|
|
FDA Approves Changes to REMS for Romiplostim and Eltrombopag
FDA Updates;
12/06/2011
The Food and Drug Administration (FDA) approved changes to the Risk Evaluation and Mitigation Strategies (REMS) for romiplostim (Nplate for subcutaneous injection, Amgen Inc.) and eltrombopag (Promacta tablets, GlaxoSmithKline LLC) to remove the restricted distribution programs and the safety reporting requirements that were part of the REMS. Prescriber, institution, pharmacy, and patient enrollment and these data collection requirements are no longer necessary.
|
|
NCI Launches Smoking Cessation Support for Teens
Legislative Updates;
12/05/2011
A new effort to help teens quit smoking will use one of today's teen's most constant companions - the mobile phone. Developed by smoking cessation experts, SmokefreeTXT is a free text message cessation service that provides 24/7 encouragement, advice, and tips to teens trying to quit smoking.
|
|
New Breast Cancer Survivor Research Underscores Need for Quality Measures
ONS News;
11/22/2011
The ONS Foundation and the Cancer Support Community (CSC) are advancing the understanding of the needs of, and treatment for, breast cancer survivors through two multi-year projects, both funded by The Breast Cancer Fund of National Philanthropic Trust starting in 2009.
|
|
FDA Approves Asparaginase Erwinia Chrysanthemi for ALL
FDA Updates;
11/18/2011
The US Food and Drug Administration approved asparaginase Erwinia chrysanthemi [ErwinazeTM, injection, EUSA Pharma (USA), Inc.] as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.
|
|
President Obama: Great American Smokeout
Legislative Updates;
11/18/2011
President Obama: Congratulations to Everyone Taking Part in Today's Great American Smokeout.
|
|
FDA Approves Ruxolitinib (Jakafi oral tablets, Incyte Corporation) for the treatment of intermediate and high risk myelofibrosis
FDA Updates;
11/16/2011
The US Food and Drug Administration approved ruxolitinib (Jakafi oral tablets, Incyte Corporation) for the treatment of intermediate and high risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.
|
|
FDA Approves Cetuximab
FDA Updates;
11/07/2011
The US Food and Drug Administration approved cetuximab (Erbitux®, ImClone LLC, a wholly-owned subsidiary of Eli-Lilly and Company) in combination with platinum-based therapy plus 5-florouracil (5-FU) for the first-line treatment of patients with recurrent locoregional disease and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
|
|
NIH Researchers Design Light Therapy
Legislative Updates;
11/07/2011
NIH researchers created a light-based therapy that targets and destroys certain tumors and cancers in mice, according to the NCI.
|
|
ONS Announces Updates to its Research Agenda
ONS News;
10/28/2011
The Oncology Nursing Society (ONS) announces that its Research Agenda, which focuses on gaps in the knowledge base for oncology nursing practice, was updated in 2011.
|
|
ONS Collaborates with CDC to Develop an Infection Control and Prevention Plan for Outpatient Oncology Services
ONS News;
10/25/2011
The CDC has released a new program called Preventing Infections in Cancer Patients. The program consists of two new tools for patients, their caregivers, and their healthcare providers.
|
|
CDC Releases Most Comprehensive Melanoma Report in the US to Date
Legislative Updates;
10/19/2011
Melanoma skin cancer has a costly and deadly impact on America. The CDC releases the most comprehensive melanoma report in the United States to date.
|
|
FDA Grants Accelerated Approval to Deferiprone
FDA Updates;
10/14/2011
The US Food and Drug Administration granted accelerated approval to deferiprone (Ferriprox® Tablets, ApoPharma, Inc.), an oral iron chelator for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.
|
|
Breast Cancer Awareness Month
Legislative Updates;
10/06/2011
Read a statement from Secretary Sebilius about National Breast Cancer Awareness Month.
|
|
White House Goes Pink
Legislative Updates;
10/06/2011
October is National Breast Cancer Awareness Month – a time to remember those who have lost their lives to breast cancer and those who are battling it now, and to celebrate with those who have survived. It is also a time to reaffirm our commitment to fighting breast cancer and to remind ourselves of the importance of prevention and early detection.
|
|
Changes in Bevacizumab Package Insert
FDA Updates;
10/03/2011
Changes in bevacizumab (Avastin®, Genentech, Inc.) package insert regarding: risk of ovarian failure, osteonecrosis of the jaw, risk of venous thromboembolic event (VTE) and bleeding in patients receiving anticoagulation therapy after first VTE event.
|
|
FDA Grants Accelerated Approval for Eculizumab
FDA Updates;
09/23/2011
the U.S. Food and Drug Administration (FDA) granted accelerated approval for the use of eculizumab (Soliris®, Alexion, Inc.) for the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS).
|
|
New Guiding Principles Will Protect ONS's Integrity and Reputation
ONS News;
09/20/2011
The ONS Board of Directors approved a new set of guiding principles for corporate support and conflicts of interest (COIs) that is designed to provide a framework for relationships and interactions between ONS and for-profit organizations.
|
|
ONS Board Announces 2012-2016 Strategic Plan
ONS News;
09/20/2011
After conducting a thorough scan of the oncology healthcare environment, the Oncology Nursing Society (ONS) developed a new five-year strategic plan, which will take effect in 2012.
|
|
ONS Overhauls Position Statement Program to Better Address Current Cancer Care Environment
ONS News;
09/20/2011
During its July 2011 Board meeting, the ONS Board of Directors conducted a thorough review of Society’s current position statements and noted that some of the current positions no longer speak to a perspective unique to ONS, may no longer be relevant, or are now common practice. As a result, some positions will be revised, some will be combined together and retitled, and others will be archived as they currently stand, with possible key components incorporated into other positions as applicable.
|
|
ONS Revamps Approach to Leadership Development
ONS News;
09/20/2011
The ONS Leadership Development Institute (LDI) was held annually from 1998–2010. Although the program was well received, the number of nurses participating was limited each year. In response to the current economic climate, the ONS Board of Directors and staff decided to step back and re-evaluate the program, as well as define the leadership needs of the ONS membership and the organization as a whole.
|
|
FDA Grants Approval for Denosumab
FDA Updates;
09/16/2011
The US Food and Drug Administration granted approval for denosumab (Prolia®, Amgen Inc.) as a treatment to increase bone mass in patients at high risk for fracture receiving androgen deprivation therapy (ADT) for nonmetastatic prostate cancer or adjuvant aromatase inhibitor (AI) therapy for breast cancer. In men with nonmetastatic prostate cancer, denosumab also reduced the incidence of vertebral fracture.
|
|
Patient Navigation Supplement Cosponsored by ONS is Published
ONS News;
09/16/2011
Together with the American Cancer Society, ONS cosponsored a special supplement that focuses on the importance of patient navigation.
|
|
Lung Cancer Rates Decline Nationnwide
Legislative Updates;
09/15/2011
A new report shows a continuing decline in rates of new lung cancer cases among men, and a promising decline among women.
|
|
ONS Hosts First All-Virtual Conference
ONS News;
09/12/2011
Nurses from across the country gathered for the Oncology Nursing Society’s (ONS) Radiation eConference: Radiation Then and Now, and they never had to leave their hometowns. The Radiation eConference is ONS’s first all virtual event.
|
|
CDC Releases New Report on Smoking
Legislative Updates;
09/07/2011
The CDC releases a new report on smoking. While heavy smoking decreases, light smoking increases.
|
|
ONS Offers Resources for Safe Handling of Chemotherapy
ONS News;
09/07/2011
Unintentional exposure to hazardous agents such as chemotherapy may endanger the lives of healthcare workers. The Oncology Nursing Society (ONS) offers resources designed to educate nurses on safe handling procedures.
|
|
Call for Nurse in Washington Internship Applicants
ONS News;
09/02/2011
The Nurse in Washington Internship (NIWI) Program is an annual event sponsored by the Nursing Organizations Alliance. The purpose of the NIWI Program is to provide nurses the opportunity to learn how to influence health care through legislative and regulatory processes. Participants learn from health policy experts and government officials and network with other nurses. The next NIWI is scheduled to be held February 26–28, 2012, in Washington, DC. This year, ONS is offering a limited number of grants for nurses to attend NIWI. The deadline to apply for the grant is November 1, 2011. Recipients of the grants will receive full registration for NIWI, expenses for travel and hotel, and a per diem.
|
|
NIH-Funded Researchers Discover Genetic Link to Mesothelioma
Legislative Updates;
08/29/2011
Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer -- mesothelioma, and melanoma of the eye. Additionally, when these individuals are exposed to asbestos or similar mineral fibers, their risk of developing mesothelioma, an aggressive cancer of the lining of the chest and abdomen, may be markedly increased
|
|
FDA Grants Accelerated Approval to Crizotinib
FDA Updates;
08/26/2011
The US Food and Drug Administration granted accelerated approval to crizotinib (XALKORI® Capsules, Pfizer Inc.) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
|
|
FDA Grants Accelerated Approval to Brentuximab Vedotin
FDA Updates;
08/19/2011
The US Food and Drug Administration granted accelerated approval to brentuximab vedotin (Adcetris™ for Injection, Seattle Genetics, Inc.) for two indications:
• The treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates.
• The treatment of patients with systemic anaplastic large cell lymphoma (ALCL) after failure of at least one prior multi-agent chemotherapy regimen.
|
|
FDA Approves Vemurafenib Tablets
FDA Updates;
08/17/2011
The US Food and Drug Administration approved vemurafenib tablets (ZELBORAFTM, Hoffmann-La Roche Inc.) for the treatment of patients with unresectable or metastatic melanoma with the BRAFV600E mutation as detected by an FDA-approved test.
|
|
NIH Releases Study Implicating Cigarette Smoking in Half of Bladder Cancers in Women
Legislative Updates;
08/16/2011
NIH study confirms bladder cancer risk from smoking is higher than previously estimated.
|
|
HHS Awards $71.3 Million to Strengthen Nursing Workforce
Legislative Updates;
07/29/2011
The Department of Health and Human Services announces $71.3 million in nursing workforce grants to support training, diversity, and nursing faculty.
|
|
ONS Journal CJON Accepted for Indexing and Earned High Impact Factor
ONS News;
07/20/2011
The Oncology Nursing Society (ONS) is pleased to announce that the Clinical Journal of Oncology Nursing (CJON), an award-winning publication of ONS, has been accepted for indexing in Web of ScienceSM, the largest and most comprehensive citation index available.
|
|
Jill Hamilton, PhD, RN, Receives ONS Publishing Division Award
Awards Granted;
07/14/2011
Jill Hamilton, PhD, RN, is the recipient of the Oncology Nursing Society (ONS) Publishing Division’s Excellence in Writing Award for Qualitative Nursing Research.
|
|
ONS Receives Awards for Publishing Excellence
ONS News;
07/06/2011
The Oncology Nursing Society (ONS) was recently honored with several awards for its publishing excellence.
|
|
CDC Releases Report on Colorectal Cancer
Legislative Updates;
07/05/2011
The CDC released a report on colorectal cancer with current data on colorectal cancer screening, incidence, and mortality.
|
|
Oncology Nursing Society Hosts Meeting of National Healthcare Quality Leaders
ONS News;
06/29/2011
As a leading force in the drive to bring the highest quality care to all patients, the Oncology Nursing Society (ONS) hosted a multidisciplinary dialogue on measuring care at its headquarters this week.
|
|
FDA Unveils Final Cigarette Warning Labels
Legislative Updates;
06/21/2011
The U.S. Food and Drug Administration (FDA) today unveiled the nine graphic health warnings required to appear on every pack of cigarettes sold in the United States and in every cigarette advertisement.
|
|
112th Congressional Nursing Caucus
Legislative Updates;
06/16/2011
Encourage your representative in Congress to become a member of the House Nursing Caucus.
|
|
IOM Releases New Report - Patient-Centered Cancer Treatment Planning Improving the Quality of Oncology Care - Summary of a Workshop
Legislative Updates;
06/15/2011
The life-threatening nature of cancer and the complexity of cancer treatment options, each with its own set of potential risks and benefits, make it difficult for people with cancer to make decisions about their care.
|
|
The FDA Sheds Light on Sunscreens
FDA Updates;
06/15/2011
The Food and Drug Administration (FDA) is taking steps to help protect consumers from skin damage caused by excessive sun exposure.
|
|
ONS Submits Formal Testimony
Legislative Updates;
06/07/2011
ONS submitted formal testimony to the NIH regarding prescription medication.
|
|
Marcelle Kaplan, RN, MS, AOCN®, CBCN®, Chosen 2011 Advanced Oncology Certified Nurse of the Year
Awards Granted;
06/03/2011
The Oncology Nursing Certification Corporation (ONCC) has selected Marcelle Kaplan, RN, MS, AOCN®, CBCN® as the 2011 Advanced Oncology Certified Nurse of the Year. Kaplan won the award for her significant contributions to oncology nursing and oncology nursing service and for supporting and promoting certification in oncology nursing.
|
|
Maureen O'Hara, RN, MSN, OCN®, Named 2011 Oncology Certified Nurse of the Year
Awards Granted;
06/03/2011
The Oncology Nursing Certification Corporation (ONCC) has selected Maureen O’Hara, RN, BSN, OCN® as the 2011 Oncology Certified Nurse of the Year. O’Hara was selected for the award for her contributions to oncology nursing and oncology nursing service and for supporting and promoting certification in oncology nursing.
|
|
ONCC Presents Employer Recognition Award
Awards Granted;
06/03/2011
The Oncology Nursing Certification Corporation (ONCC) has selected Springfield Oncology Hematology Associates (OHA) in Springfield, MO, as a recipient of its 2011 Employer Recognition Award. Each year this award recognizes one organization that employs less than 25 registered nurses for providing sustained support of oncology nursing certification.
|
|
ONCC Presents Second Employer Recognition Award
Awards Granted;
06/03/2011
The Oncology Nursing Certification Corporation (ONCC) has selected Georgetown University Hospital, as a recipient of its 2011 Employer Recognition Award. Each year this award recognizes one organization that employs 25 or more registered nurses for their sustained support of oncology nursing certification.
|
|
Susan Bowman, RN, OCN, CBCN, MSW Named Certified Breast Care Nurse of the Year
Awards Granted;
06/03/2011
The Oncology Nursing Certification Corporation (ONCC) has selected Susan Bowman, RN, OCN®, CBCN®, MSW as the 2011 Certified Breast Care Nurse of the Year.
|
|
Laurie Dohnalek, RN, MBA, NE-BC Receives ONS Excellence in Health Policy and Advocacy Award
Awards Granted;
05/25/2011
Laurie Dohnalek, RN, MBA, NE-BC, is the recipient of the 2011 Oncology Nursing Society (ONS) Excellence in Oncology Nursing Health Policy and Advocacy Award. This award recognizes and supports her achievements and involvement in oncology nursing health policy and advocacy.
|
|
FDA Approves Sunitinib
FDA Updates;
05/24/2011
The US Food and Drug Administration approved sunitinib (Sutent® Capsules, Pfizer, Inc.) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in patients with unresectable, locally advanced, or metastatic disease.
|
|
Laurie Dohnalek, RN, MBA, NE-BC, Receives ONS Excellence in Oncology Nursing Health Policy and Advocacy Award
Legislative Updates;
05/20/2011
ONS Health Policy Director Alec Stone congratulates ONS member and 2011 Advocacy Award winner Laurie J. Dohnalek, RN, MBA, NE-BC after receiving her plaque for outstanding contributions in oncology nursing health policy advocacy.
|
|
ONS Signs on to Prevent Healthcare-Associated Infections
Legislative Updates;
05/19/2011
The Oncology Nursing Society (ONS) joined the U.S. Department of Health and Human Services along with hospitals, healthcare providers, and other organizations in the Partnership for Patients to make hospital care safer, more reliable, and less costly.
|
|
Sebelius Recognizes Nurses for Their Commitment, Leadership, and Vision
Legislative Updates;
05/12/2011
Kathleen Sebelius, secretary of the U.S. Department of Health and Human Services, recognized the contributions of nurses and thanked them for their critical work in an official statement released in honor of National Nurses Week.
|
|
FDA Approves Everolimus
FDA Updates;
05/05/2011
The U.S. Food and Drug Administration approved everolimus (Afinitor® Tablets, Novartis Pharmaceuticals Corporation), for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease.
|
|
ONS Signs on Support to Maintain Prevention and Public Health Fund
Legislative Updates;
05/04/2011
With the concern about the future implementation of the Patient Protection and Affordable Care Act (PPACA) and the current economic environment, ONS has joined a number of other cancer organizations in raising Congress's awareness of the importance of a key prevention and detection fund included in the original legislation.
|
|
ONS Announces 2011-2012 Board of Directors
ONS News;
04/30/2011
The Oncology Nursing Society (ONS) announced its 2011–2012 Board of Directors at its 36th Annual Congress in Boston, MA.
|
|
ONS Joins Journey Forward Collaborative to Benefit Cancer Survivors
ONS News;
04/28/2011
The Oncology Nursing Society (ONS) has joined the Journey Forward collaborative to promote cancer survivorship through the use of Survivorship Care Plans.
|
|
Judith Johnson, PhD, RN, FAAN, Receives ONS Lifetime Achievement Award
Awards Granted;
04/25/2011
Judith Johnson, PhD, RN, FAAN, is the recipient of the 2011 Oncology Nursing Society (ONS) Lifetime Achievement Award. The award recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large.
|
|
Martha Langhorne, MSN, RN, FNP, AOCN®, Receives Pearl Moore Making A Difference Award
Awards Granted;
04/25/2011
Martha Langhorne, MSN, RN, FNP, AOCN®, is the 2011 recipient of the Oncology Nursing Society (ONS) Pearl Moore Making a Difference Award. The award recognizes her significant contributions to the oncology nursing profession at the local and regional levels
|
|
ONS Hires Executive Director of Professional Practice and Programs
ONS News;
04/19/2011
The Oncology Nursing Society (ONS) has hired Elizabeth Wertz Evans, RN, BSN, MPM, FACMPE, CPHQ, CPHIMS, to serve as executive director of professional practice and programs. She will lead ONS’s division that oversees education, publishing, research, library/archives, and international initiatives.
|
|
ONS Member Patrick Coyne, MSN, APN, FAAN Testifies Before Congressional Committee on Need for Continued Access to Pain Medication for Patients With Cancer
Legislative Updates;
04/14/2011
ONS member Patrick Coyne, MSN, APN, FAAN, was a witness and testified on behalf of the broad patient and provider communities regarding pain relief at a hearing "Warning: The Growing Danger of Prescription Drug Diversion."
|
|
FDA Approves Vandetanib Tablets
FDA Updates;
04/12/2011
The U. S. Food and Drug Administration approved vandetanib tablets (Vandetanib Tablets, AstraZeneca Pharmaceuticals LP), a kinase inhibitor, for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable, locally advanced, or metastatic disease. The use of vandetanib in patients with indolent, asymptomatic or slowly progressing disease should be carefully considered because of the treatment-related risks of vandetanib.
|
|
ONS Board Makes Changes to National Conference Offerings for 2012
ONS News;
04/11/2011
The ONS Board of Directors approved some exciting new changes to ONS’s national conference offerings at its March 2011 meeting. These changes are in direct response to customer feedback and the changing landscape of healthcare meetings and education.
|
|
ONS PEP Resources Now Included in National Guidelines
ONS News;
04/04/2011
ONS’s Putting Evidence Into Practice (PEP®) guidelines are now included in the National Guideline Clearinghouse (NGC), an initiative of the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ).
|
|
FDA Approves Peginterferon Alfa-2B
FDA Updates;
03/29/2011
The U.S. Food and Drug Administration approved peginterferon alfa-2b (Sylatron™, Schering Corporation, Kenilworth, NJ 07033), for the treatment of patients with melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection including complete lymphadenectomy.
|
|
FDA Approves Ipilimumab Injection
FDA Updates;
03/25/2011
The U. S. Food and Drug Administration approved ipilimumab injection (YERVOY ®, Bristol-Myers Squibb Company) for the treatment of unresectable or metastatic melanoma.
|
|
David Makumi-Kinyanjui, RN, MPC(c), Receives ONS International Award
Awards Granted;
03/24/2011
David Makumi-Kinyanjui, RN, MPC(c), is the 2011 recipient of the Oncology Nursing Society (ONS) International Award for Contributions to Cancer Care. The award recognizes his contribution in drawing the attention of the country to the cancer crisis and his leadership in empowering nurses and ordinary Kenyans with knowledge and skills to respond to the growing cancer problem.
|
|
Donna L. Berry, PhD, RN, AOCN®, FAAN, Receives 2011 Oncology Nursing Society Distinguished Researcher Award
Awards Granted;
03/17/2011
Donna L. Berry, PhD, RN, AOCN®, FAAN, has been named the Oncology Nursing Society’s (ONS) 2011 Distinguished Researcher.
|
|
Update on the Institute of Medicine Report on the Future of Nursing
ONS News;
03/08/2011
The Oncology Nursing Society (ONS) has developed a number of tactics that address the key messages identified in the Institute of Medicine (IOM) Report on the Future of Nursing, which was published in October 2010.
|
|
Bakitas Receives ONS 2011 New Investigator Award
Awards Granted;
02/12/2011
Marie Anne Bakitas, DNSc, APRN, NP-C, AOCN®, ACHPN, FAAN, was presented the Oncology Nursing Society (ONS) 2011 Victoria Mock New Investigator Award today at the ONS 11th National Conference on Cancer Nursing Research in Los Angeles, CA.
|
|
Donald Bailey, Jr., PhD, RN, Presents 2011 Oncology Nursing Society State-of-the-Science Lecture
Awards Granted;
02/11/2011
Donald Bailey, Jr., PhD, RN, presented the 2011 Oncology Nursing Society (ONS) State-of-the-Science Lecture, “Illness Uncertainty in Adult Cancer Patients,” today during the ONS 11th National Conference on Cancer Nursing Research in Los Angeles.
|
|
Just Being at High Risk for Breast Cancer Is a Life-Changing Experience
Press Releases;
02/11/2011
Young African American women at high risk for breast cancer described the risk itself as a life-changing experience, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research.
|
|
Study Supports Forgoing Axillary Dissection in Some Patients With Breast Cancer
ONS News;
02/11/2011
A study published Wednesday in JAMA found that, among a small subset of patients with breast cancer, axillary dissection in patients with sentinel node metastases does not significantly affect survival rates. The study was covered by the mainstream media with a New York Times’ reporter describing it as turning “standard medical practice on its head.” Although the findings are exciting for breast cancer patients, nurses play a key role in helping patients understand the limitations of the findings.
|
|
Whether They Smoke or Not, Patients Say Lung Cancer Diagnosis Carries a Social Stigma
Press Releases;
02/11/2011
Patients with lung cancer, whether they smoke or not, feel stigmatized because their disease is strongly associated with smoking, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research.
|
|
Study Finds More Survivorship Programs Needed; Time and Funding Present the Greatest Barriers
ONS News;
02/08/2011
An estimated 12 million people are cancer survivors, yet only 27% of nurses working in oncology report that their practice has a formal survivorship program.
|
|
FDA Approves Rituximab
FDA Updates;
01/28/2011
the U.S. Food and Drug Administration approved rituximab (Rituxan®, Genentech, Inc) for maintenance therapy for patients with previously untreated follicular, CD-20 positive, B-cell non-Hodgkin lymphoma who achieve a response to rituximab in combination with chemotherapy.
|
|
ONS Partners With Advocacy Groups for Ice Skating Spectacular
ONS News;
12/17/2010
The Oncology Nursing Society (ONS) has joined leading cancer advocacy groups and professional associations to support an education and awareness platform around cancer survivorship through a holiday television special called Kaleidoscope on Ice.
|
|
LDI on Hold for 2011
ONS News;
12/08/2010
For many years, the ONS Leadership Development Institute (LDI) has brought together hundreds of participants from a variety of backgrounds for a three-day leadership conference followed by a year of mentorship and goal accomplishment. Due to changing needs, the decision has been made to take a step back from our current LDI program in 2011 and allow for a period of assessment and reflection. Therefore, ONS will not offer LDI in 2011. We look forward to a continued tradition of excellence in leadership programming that will address the needs of nurses in the future.
|
|
One Nurse is Special to Many
ONS News;
12/08/2010
Of all the nominations received for Honor Someone Special, no one has been named more than Mary Diffendall, RN, OCN®. Mary, an oncology nurse at Connecticut Oncology Group in Middletown, has been nominated for Honor Someone Special 26 times, often by her patients. Here is what is being said about Mary.
|
|
FDA Approves Denosumab
FDA Updates;
11/18/2010
The U.S. Food and Drug Administration granted approval for denosumab (Xgeva™, Amgen Inc.) for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. Denosumab is not indicated for the prevention of SREs in patients with multiple myeloma.
|
|
FDA Grants Approval for Eribulin Mesylate
FDA Updates;
11/15/2010
The US Food and Drug Administration granted approval for eribulin mesylate (Halaven™ Injection, Eisai Inc.) for the treatment of patients with metastatic breast cancer who have previously received an anthracycline and a taxane in either the adjuvant or metastatic setting, and at least two chemotherapeutic regimens for the treatment of metastatic disease.
|
|
Labeling Changes Regarding Safety Information for Trastuzumab
FDA Updates;
11/02/2010
This notice is to inform you of important new safety information regarding the already labeled adverse reaction of oligohydramnios (decreased amniotic fluid).
|
|
FDA Grants Accelerated Approval to Everolimus
FDA Updates;
10/29/2010
the U.S. Food and Drug Administration granted accelerated approval to everolimus (Afinitor®, Novartis), an mTOR inhibitor, for patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS) who require therapy but are not candidates for surgical resection.
|
|
ONS Secures New Tenant
ONS News;
10/29/2010
Industrial Scientific Corporation has signed a lease with the Oncology Nursing Society (ONS) in RIDC Park West. The 35,000-square foot Findlay Township location will serve as their primary development and commercial facility. The company’s corporate headquarters is located in Oakdale.
|
|
FDA Grants Accelerated Approval to Dasatinib
FDA Updates;
10/28/2010
The U.S. Food and Drug Administration granted accelerated approval to dasatinib [Sprycel®, Bristol-Myers Squibb], an orally administered kinase inhibitor, for the treatment of newly diagnosed adult patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (CP-CML).
|
|
FDA Grants Approval for Trastuzumab in Combination With Other Drugs
FDA Updates;
10/20/2010
The US Food and Drug Administration granted approval for trastuzumab (Herceptin®), Genentech, Inc.), in combination with cisplatin and a fluoropyrimidine (capecitabine or 5-fluorouracil), for the treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal (GE) junction adenocarcinoma, who have not received prior treatment for metastatic disease.
|
|
White House Goes Pink to Raise Awareness for Breast Cancer
Legislative Updates;
10/14/2010
At 6:30 pm October 14, the White House was bathed in a soft pink light to make a public statement about breast cancer awareness month.
|
|
Changes in Measurement of Serum Creatinine May Impact Carboplatin Dosing
FDA Updates;
10/08/2010
Recent changes in the measurement of serum creatinine may have an impact on carboplatin dosing.
|
|
Call for NIWI Applicants
Legislative Updates;
10/07/2010
The Nurse in Washington Internship (NIWI) Program is an annual event sponsored by the Nursing Organizations Alliance (The Alliance). With over 60 member organizations, ONS among them, The Alliance represents approximately 500,000 nurses. The Alliance sponsors the internship to promote the interests of its member groups through education, research, and health-policy activities. Over the years, more than one thousand nurses have attended NIWI, many of whom have become influential participants in the political process at state and federal levels.
|
|
ONS Applauds IOM Report on the Future of Nursing
Legislative Updates;
10/07/2010
The Institute of Medicine’s latest consensus report on the “The Future of Nursing: Leading Change, Advancing Health” provides support for the crucial role of nursing in addressing the increased demand for services expected from healthcare reform legislation.
|
|
Cindy Tofthagen, PhD, ARNP, AOCNP, Receives ONS Foundation Research Fellowship
Awards Granted;
09/30/2010
|
|
ONS Receives Website Honors
Press Releases;
09/30/2010
The Oncology Nursing Society (ONS) was honored by the Web Marketing Association with awards for their website excellence.
|
|
Three ONS Members Named Among Top 10 Influential Nursing Professors
Press Releases;
09/24/2010
PITTSBURGH, PA – September 24, 2010 – Three ONS members have been named to the list of the top 10 most influential nursing professors by the Mister Medicine blog.
|
|
HRSA Study Finds Nursing Workforce is Growing
Legislative Updates;
09/22/2010
The Health Resources and Services Administration (HRSA) recently presented a report showing that the nursing workforce increased by more than 5% between 2004 and 2008.
|
|
Johanns' Amendment Rejected by US Senate
Legislative Updates;
09/13/2010
The United States Senate rejected Senator Mike Johanns’ (R-NE) amendment to the Small Business Jobs and Credit Act.
|
|
ONS Prepares for Fall Conferences
ONS News;
08/12/2010
ONS prepares for the 11th Annual Institutes of Learning and ONS Advanced Practice Nursing Conferences in Orlando.
|
|
Oncology Nursing Society Sponsors the Institute of Medicine’s National Cancer Policy Forum
Press Releases;
07/30/2010
PITTSBURGH, PA – July 30, 2010 – The Oncology Nursing Society (ONS) is pleased to announce its sponsorship of the Institute of Medicine’s (IOM) National Cancer Policy Forum. The Forum explores emerging policy issues in the nation’s effort to combat cancer and enables all members to be full participants in identifying and debating critical issues and examining potential actions.
|
|
ONS President Addresses FDA
Legislative Updates;
07/26/2010
PITTSBURGH, PA – July 26, 2010 – Oncology Nursing Society (ONS) President Carlton Brown, RN, PhD, AOCN®, testified before a U.S. Food and Drug Administration (FDA) committee in Washington, DC, regarding the proposed Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting Opioid Analgesics, which seeks to address the issue of opioid misuse and abuse. The CoC has replied to the letter, indicating that it intends to take some of ONS’s suggestions.
|
|
Healthcare Reform: What Does it Mean to You and Your Patients?
Legislative Updates;
07/17/2010
View slide presentation from the 2010 ONS Mentorship session.
|
|
ONS Celebrates Milestone
Press Releases;
07/02/2010
PITTSBURGH, PA – July 2, 2010 – The Oncology Nursing Society (ONS) is celebrating its 35th anniversary as a professional association providing membership benefits to more than 36,000 registered nurses who specialize in caring for patients with cancer.
|
|
Pfizer Inc. Announces that Commercial Marketing of Mylotarg (gemtuzumab ozogamicin) Will be Voluntarily Discontinued and the New Drug Application for Mylotarg Will be Withdrawn as of October 15, 2010.
FDA Updates;
06/21/2010
On June 21, 2010, Pfizer Inc., in agreement with the FDA, announced that the commercial marketing of Mylotarg (gemtuzumab ozogamicin) will be voluntarily discontinued, and the new drug application (NDA) for Mylotarg will be withdrawn as of October 15, 2010.
|
|
FDA Approves Cabazitaxel
FDA Updates;
06/17/2010
On June 17, 2010, the U.S. Food and Drug Administration (FDA) approved cabazitaxel (Jevtana® Injection, sanofi-aventis) for use in combination with prednisone for treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing regimen.
|
|
FDA Grants Accelerated Approval to Nilotinib
FDA Updates;
06/17/2010
On June 17, 2010, the U. S. Food and Drug Administration granted accelerated approval to nilotinib (Tasigna® Capsules, Novartis Pharmaceuticals Corporation), an orally administered kinase inhibitor, for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP-CML).
|
|
ONS Awarded for Publishing Excellence
Press Releases;
06/15/2010
PITTSBURGH, PA – June 15, 2010 – The Oncology Nursing Society (ONS) was honored by the Association Media and Publishing as a winner of the esteemed EXCEL Award in two categories at its recent 30th Annual EXCEL Awards Gala in Washington, DC.
|
|
ONS Provides Key Nursing Resources to Support Cancer Clinical Trials Recommendations
ONS News;
05/28/2010
The Oncology Nursing Society’s (ONS’s) long-standing efforts to support clinical trials funding and access to participation are in line with recommendations offered in the Institute of Medicine’s (IOM’s) recent report on the Cooperative Group Program and the American Society of Clinical Oncology’s (ASCO’s) response to the report.
|
|
New bill delays medicare pay cut until 2014, provides raises in interim.
Legislative Updates;
05/20/2010
Congressional Democrats today unveiled the outline of a bill that would delay a 21% cut in Medicare reimbursement to physicians until 2014 and increase rates for the rest of 2010 as well as 2011.
|
|
ONS Announces 2010–2011 Board of Directors
Press Releases;
05/15/2010
SAN DIEGO, CA – May 15, 2010 – The Oncology Nursing Society (ONS) announced its 2010–2011 Board of Directors at its 35th Annual Congress in San Diego, CA.
|
|
Connie Henke Yarbro, MS, RN, FAAN, Receives 2010 Oncology Nursing Society Lifetime Achievement Award
Awards Granted;
05/13/2010
SAN DIEGO, CA – May 13, 2010 – Connie Henke Yarbro, MS, RN, FAAN, of Destin, FL, is the recipient of the 2010 Oncology Nursing Society (ONS) Lifetime Achievement Award. Yarbro is the editor of Seminars in Oncology Nursing and an adjunct clinical associate professor at the University of Missouri-Columbia Sinclair School of Nursing. The award, presented today at the ONS 35th Annual Congress held in San Diego, CA, recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large.
|
|
Oncology Nursing and Social Work Professional Associations
Press Releases;
04/13/2010
PITTSBURGH, PA – April 13, 2010 – The Oncology Nursing Society (ONS), the Association of Oncology Social Work (AOSW), and the National Association of Social Workers (NASW) worked together to develop a joint position statement on the role of oncology nursing and oncology social work in patient navigation.
|
|
New ESA Risk Management System
Legislative Updates;
02/16/2010
|
|
ONS Joins the Nursing Community to Advocate for Nursing Provisions
Legislative Updates;
01/06/2010
ONS joined with others in the nursing community to advocate for nursing provisions.
|
|
ONS Members Attend White House Briefing
Legislative Updates;
09/10/2009
|
|
ONS Written Comments to the FDA
Legislative Updates;
06/26/2009
ONS submitted written comments to the Food and Drug Administration (FDA) related to the possibility that the FDA will create a Risk Evaluation and Mitigation Strategies (REMS) for certain opioid drugs.
|
|
ONS Testimony for FDA Public Opioid REMS Meeting
Legislative Updates;
05/27/2009
This is a synopsis of the testimony ONS delivered to the FDA on May 27th, 2009.
|
|
Commitment to Quality Health Reform
Legislative Updates;
05/01/2009
Commitment to Quality Health Reform: A Consensus Statement from the Nursing Community
|
|
Health Policy Update April 2009
Legislative Updates;
04/01/2009
Health Policy Update April 2009
|
|
Cancer and Nursing in the Stimulus Package
Legislative Updates;
02/17/2009
President Obama signed the economic stimulus bill (H.R. 1) into law.
|
|
ONS Helps Secure Expanded Medicare Off-Label Coverage for Anticancer Therapies
Legislative Updates;
01/15/2009
Congress and the Centers for Medicare and Medicaid Services (CMS) took action to expand off-label cancer therapy coverage for Medicare beneficiaries
|
|
Role of the Oncology RN in Outpatient Medical Oncology
Legislative Updates;
01/02/2009
ONS and US Oncology joined together to develop publication.
|
